Evidence map›Paper›PMID 25742269›Full record

ArticleMemorias do Instituto Oswaldo Cruz2015

Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance.

Thiago Moreno Lopes e Souza, Natalia Fintelman-Rodrigues, Paola Cristina Resende, Milene Mesquita, Tatiana Schaffer Gregianini, Fernando A Bozza, Ana Carla Pecego, Sandra Bianchini Fernandes, Ana Luisa Furtado Cury, Irina Nastassja Riediger and 1 more

Abstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thiago Moreno Lopes e SouzaLaboratório de Vírus Respiratórios e do Sarampo.
Natalia Fintelman-RodriguesLaboratório de Vírus Respiratórios e do Sarampo.
Paola Cristina ResendeLaboratório de Vírus Respiratórios e do Sarampo.
Milene MesquitaLaboratório de Vírus Respiratórios e do Sarampo.
Tatiana Schaffer GregianiniFundação Estadual de Produção e Pesquisa em Saúde, Porto Alegre, RS, Brasil.
Fernando A BozzaInstituto de Pesquisas Clínicas Evandro Chagas.
Ana Carla PecegoInstituto de Pesquisas Clínicas Evandro Chagas.
Sandra Bianchini FernandesEstado de Santa Catarina, Florianópolis, SC, Brasil.
Ana Luisa Furtado CuryInstituto Octávio Magalhães, Fundação Ezequiel Dias, Belo Horizonte, MG, Brasil.
Irina Nastassja RiedigerEstado do Paraná, PR, Brasil.
Marilda M SiqueiraLaboratório de Vírus Respiratórios e do Sarampo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2009 pandemic influenza A virus outbreak led to the systematic use of the neuraminidase (NA) inhibitor oseltamivir (OST). Consequently, OST-resistant strains, carrying the mutation H275Y, emerged in the years after the pandemics, with a prevalence of 1-2%. Currently, OST-resistant strains have been found in community settings, in untreated individuals. To spread in community settings, H275Y mutants must contain additional mutations, collectively called permissive mutations. We display the permissive mutations in NA of OST-resistant A(H1N1)pdm09 virus found in Brazilian community settings. The NAs from 2013 are phylogenetically distinct from those of 2012, indicating a tendency of positive selection of NAs with better fitness. Some previously predicted permissive mutations, such as V241I and N369K, found in different countries, were also detected in Brazil. Importantly, the change D344N, also predicted to compensate loss of fitness imposed by H275Y mutation, was found in Brazil, but not in other countries in 2013. Our results reinforce the notion that OST-resistant A(H1N1)pdm09 strains with compensatory mutations may arise in an independent fashion, with samples being identified in different states of Brazil and in different countries. Systematic circulation of these viral strains may jeopardise the use of the first line of anti-influenza drugs in the future.

Indexed as

MutationAdultAntiviral AgentsBrazilDrug Resistance, ViralFemaleHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMutation RateNasal Lavage FluidNeuraminidaseOseltamivirPhylogenyPhylogeographyRNA, ViralAntiviral AgentsNeuraminidaseOseltamivirRNA, Viral

Identifiers

PMID25742269
PMCPMC4371223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.